NCT01248585 - Dexamethasone vs Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases | Biotech Hunter

Enrollment

298

Participants

Timeline

Start Date

May 30, 2011

Primary Completion Date

May 25, 2015

Study Completion Date

November 27, 2015

Conditions

Bone Metastases

Interventions

DRUG

Dexamethasone

2 x 4 mg dexamethasone (dex) tablets taken once daily for 5 days

DRUG

Placebo

2 placebo tablets taken once daily for 5 days

Trial Locations (22)

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

V2S 0C2

BCCA - Abbotsford Centre, Abbotsford

V5Z 4E6

BCCA - Vancouver Cancer Centre, Vancouver

V8R 6V5

BCCA - Vancouver Island Cancer Centre, Victoria

R3E 0V9

CancerCare Manitoba, Winnipeg

E1C 8X3

The Vitalite Health Network - Dr. Leon Richard, Moncton

L4M 6M2

Royal Victoria Regional Health Centre, Barrie

L8V 5C2

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton

K7L 5P9

Cancer Centre of Southeastern Ontario at Kingston, Kingston

N2G 1G3

Grand River Regional Cancer Centre, Kitchener

N6A 4L6

London Regional Cancer Program, London

L3Y 2P9

Stronach Regional Health Centre at Southlake, Newmarket

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

M4N 3M5

Odette Cancer Centre, Toronto

M5G 2M9

Univ. Health Network-Princess Margaret Hospital, Toronto

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

H2L 4M1

CHUM - Hopital Notre-Dame, Montreal

G1R 2J6

CHUQ-Pavillon Hotel-Dieu de Quebec, Québec

J1H 5N4

Centre hospitalier universitaire de Sherbrooke, Sherbrooke

S4T 7T1

Allan Blair Cancer Centre, Regina

S7N 4H4

Saskatoon Cancer Centre, Saskatoon